Literature DB >> 14084752

ENTEROMEGALY AND CARDIOMEGALY IN CHAGAS DISEASE.

F KOEBERLE.   

Abstract

Chagas disease due to a trypanosome infection may lead to extensive destruction of ganglion cells in the peripheral autonomic system and may result in gross enlargement of the oesophagus, colon, and heart. From studies on nerve cell counts it is concluded that the number of ganglion cells in the oesophagus must be reduced to less than half to produce functional disturbances in the oesophagus and to one tenth to produce a megaoesophagus. Problems of terminology are discussed.

Entities:  

Keywords:  BRAZIL; BRONCHIECTASIS; ESOPHAGUS; GANGLIA, AUTONOMIC; HEART ENLARGEMENT; MEGACOLON; STOMACH DILATATION; TRYPANOSOMIASIS, SOUTH AMERICAN

Mesh:

Year:  1963        PMID: 14084752      PMCID: PMC1413478          DOI: 10.1136/gut.4.4.399

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  6 in total

1.  [Experimental Chagas' cardiopathy. (Quantitative studies on the intracardiac nervous system)].

Authors:  F de ALCANTARA
Journal:  Z Tropenmed Parasitol       Date:  1959-11

2.  [Chagas disease: a disease of the peripheral autonomic nervous system].

Authors:  F KOBERLE
Journal:  Wien Klin Wochenschr       Date:  1956-04-27       Impact factor: 1.704

3.  The pathogenesis and clinical management of megacolon with emphasis on the fallacy of the term "idiopathic".

Authors:  C M LEE; K C BEBB
Journal:  Surgery       Date:  1951-12       Impact factor: 3.982

4.  [Megacolon and mega-esophagus in central Brazil].

Authors:  S V de FREITAS JUNIOR
Journal:  Resen Clin Cient       Date:  1950-11

5.  Hirschsprung's disease.

Authors:  M BODIAN; C O CARTER; B C H WARD
Journal:  Lancet       Date:  1951-02-10       Impact factor: 79.321

6.  [Etiopathogenesis of aperistalsis of the esophagus (cardiospasm; megaesophagus, achalasia of the cardia, etc.)].

Authors:  A BRASIL
Journal:  Rev Bras Med       Date:  1956-08
  6 in total
  23 in total

1.  Special problems in COCM: South America.

Authors:  D S Amorim
Journal:  Postgrad Med J       Date:  1978-07       Impact factor: 2.401

Review 2.  Role of autoantibodies in the physiopathology of Chagas' disease.

Authors:  Emiliano Horacio Medei; José Hamilton Matheus Nascimento; Roberto Coury Pedrosa; Antônio Carlos Campos de Carvalho
Journal:  Arq Bras Cardiol       Date:  2008-10       Impact factor: 2.000

3.  Trypanosoma cruzi-Derived Neurotrophic Factor: Role in Neural Repair and Neuroprotection.

Authors:  Marina V Chuenkova; Mercio Pereiraperrin
Journal:  J Neuroparasitology       Date:  2010-07-26

4.  Effect of CCK-OP and intraduodenal administration of essential amino acids on intraluminal pressures of sigmoid and rectum in patients with Chagasic megacolon.

Authors:  J F Macedo; U G Meneghelli; R B Oliveira; R A Godoy; L E Troncon; R O Dantas
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

5.  The response of the internal anal sphincter in man to stimulation of the presacral nerve.

Authors:  J J Shepherd; P G Wright
Journal:  Am J Dig Dis       Date:  1968-05

6.  The application of studies in vitro to the management of Hirschsprung's disease and of megacolon in adults.

Authors:  J J Shepherd; P G Wright
Journal:  Am J Dig Dis       Date:  1968-05

7.  Effect of parasympathetic impairment on the haemodynamic response to handgrip in Chagas's heart disease.

Authors:  J A Marin-Neto; B C Maciel; L Gallo Júnior; L F Junqueira Júnior; D S Amorim
Journal:  Br Heart J       Date:  1986-02

8.  Discordance for achalasia in identical twins.

Authors:  J D Eckrich; C S Winans
Journal:  Dig Dis Sci       Date:  1979-03       Impact factor: 3.199

9.  Constipation in infants and children.

Authors:  J F Bentley
Journal:  Gut       Date:  1971-01       Impact factor: 23.059

10.  Factors controlling colonic motility: colonic pressures and transit after meals in patients with total gastrectomy, pernicious anaemia or duodenal ulcer.

Authors:  D J Holdstock; J J Misiewicz
Journal:  Gut       Date:  1970-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.